Action 603880 JIANGSU NANFANG MEDICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jiangsu Nanfang Medical Co., Ltd.

Actions

603880

CNE100002WH0

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
3,82 CNY +2,14 % Graphique intraday de Jiangsu Nanfang Medical Co., Ltd. +9,46 % -24,95 %
29/03 Jiangsu Nanfang Medical Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Jiangsu Nanfang Medical Co. publie ses résultats pour les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Ren Weiguo signed share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for CNY 99.9 million.
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange A Share Index
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange Composite Index
Suzhou Fengruida Optoelectronics Technology Co., Ltd. signed a share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for approximately CNY 140 million.
Jiangsu Nanfang Medical Co., Ltd. announced that it expects to receive CNY 299.200902 million in funding from Suzhou Fengruida Optoelectronics Technology Co., Ltd.
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jiangsu Nanfang Medical Unit to Apply For 100 Million Yuan Bank Loan
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Inner Mongolia Huaxi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jiangsu Nanfang Medical Co., Ltd.
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Shen Zhezhong cancelled the acquisition of 60% stake in Shanghai Milene Biotechnology Co., Ltd.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603880
  4. Actualités Jiangsu Nanfang Medical Co., Ltd.
  5. Autres langues